BioBlast w/e 15 Dec 23
Korea Biomed reported that LG Chem’s Xelenka®, biosimilar to AbbVie’s Humira® (adalimumab), has been approved by the Korean Ministry of Food and Drug…
Source: lexology.com
Stay updated with breaking news from Plus Padcev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Korea Biomed reported that LG Chem’s Xelenka®, biosimilar to AbbVie’s Humira® (adalimumab), has been approved by the Korean Ministry of Food and Drug…